Charles Bankhead

Charles Bankhead

Authors >

Charles Bankhead

Senior Editor, MedPage Today

Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. His career spans more than 30 years, including a decade with Medical World News, a leading medical trade magazine of its time. He had a long and successful freelance career before joining MedPage Today in 2007. Charles graduated with honors from Texas Tech University, receiving a BA in journalism, and completed a master's degree in mass communication, with specialization in health communication, also at Texas Tech.

Connect:

email image

Latest from Charles Bankhead

A photo of adult male twins.

Negative Effects of Trauma May Persist for Decades After the Incident

Increased risk of death, immune illness, cancer in trauma-exposed versus unexposed twins

A photo of a dermatologist examining a patient’s mole through a dermatoscope.

Dermatologists Hone Diagnostic Accuracy for Suspect Lesions With AI 'Collaboration'

Sensitivity, specificity, mean accuracy, and AUC improved significantly with neural network input

Onco Break over a computer rendering of a cancer cell.

Drug Shortages Hit Oncology; Telemedicine Tops In-Person; Sniffing Out Lung Cancer

News, features, and commentary about cancer-related issues

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

CDC: Drug-Resistant Ringworm in U.S.; Mail-In HPV Tests Work; Pope Urges Procreation

Health news and commentary from around the Web gathered by MedPage Today staff

ASCRS over a photo of the Seattle Convention Center in Seattle, WA.

Novel Drug Checks All the Boxes as Dry Eye Treatment

Also: combination tops cyclosporine, nasal spray misses mark in dry eye

ASCRS over a photo of the Seattle Convention Center in Seattle, WA.

Low-Dose Pilocarpine Improves Vision in Vehicle-Controlled Presbyopia Trials

Twice as many patients had at least three lines of improvement in distance-corrected near vision

ASCRS over a photo of the Seattle Convention Center in Seattle, WA.

Implant Matches Topical Timolol for Intraocular Pressure Control, With Good Safety

Numerical advantage for implant meets noninferiority goal, implant exchange appears safe

ASCRS over a photo of the Seattle Convention Center in Seattle, WA.

Novel Drug Fails to Improve Diabetic Retinopathy, but Slows Progression

Significantly fewer patients had 3-step worsening of DRSS with oral antiangiogenic

ASCRS over a photo of the Seattle Convention Center in Seattle, WA.

Limited Effect of Laser Treatment on Eye Floaters

No improvement in IOP or distance vision, but patients reported change in floater burden

Illustration of a patient's medical clipboard and a red medical plus icon in a circle over a heart calendar with arrows going

Melanoma: Survivorship Care

The end of treatment marks the beginning of a new journey, the transition to survivorship

1

…